Bath & Body Works, Inc. (NYSE:BBWI) Stock Holdings Decreased by Gallacher Capital Management LLC

Gallacher Capital Management LLC trimmed its position in Bath & Body Works, Inc. (NYSE:BBWI) by 6.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,301 shares of the company’s stock after selling 1,312 shares during the period. Gallacher Capital Management LLC’s holdings in Bath & Body Works were worth $710,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of BBWI. Fifth Third Wealth Advisors LLC increased its stake in Bath & Body Works by 4.9% during the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after purchasing an additional 324 shares during the last quarter. SRS Capital Advisors Inc. grew its position in shares of Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after buying an additional 329 shares during the last quarter. TD Private Client Wealth LLC grew its position in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares during the last quarter. UMB Bank n.a. grew its position in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after buying an additional 335 shares during the last quarter. Finally, Lindbrook Capital LLC grew its position in shares of Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on BBWI. Morgan Stanley lowered their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. JPMorgan Chase & Co. set a $47.00 price objective on Bath & Body Works in a research note on Thursday, February 27th. Telsey Advisory Group restated an “outperform” rating and set a $43.00 price target on shares of Bath & Body Works in a research report on Thursday, February 27th. Cowen restated a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, Bath & Body Works has a consensus rating of “Moderate Buy” and an average price target of $45.06.

Bath & Body Works Stock Up 3.8 %

Shares of BBWI stock opened at $29.54 on Friday. Bath & Body Works, Inc. has a fifty-two week low of $26.21 and a fifty-two week high of $52.99. The stock has a 50-day simple moving average of $36.36 and a 200 day simple moving average of $33.99. The stock has a market capitalization of $6.40 billion, a P/E ratio of 7.20, a P/E/G ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its board has authorized a share buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.4% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.71%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s dividend payout ratio is presently 21.98%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.